TEDAVI

Digital

Partner Content

EVERSANA, a leading provider of global commercial services to the life sciences industry, today introduced <

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.